This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
NC Andreasen (1982) Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39:784–788.
L Bardin , A Auclair , MS Kleven , EP Prinssen , W Koek , A Newman-Tancredi , R Depoortere (2007) Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behav Pharmacol 18:103–118.
MW Beltman , RC Voshaar , AE Speckens (2010) Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry 197:11–19.
AF Carvalho , JR Machado , JL Cavalcante (2009) Augmentation strategies for treatment-resistant depression. Curr Opin Psychiatry 22:7–12.
LD Cohn , BJ Becker (2003) How meta-analysis increases statistical power. Psychol Methods 8:243–253.
R DerSimonian , N Laird (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188.
A Ghaleiha , AA Noorbala , F Farnaghi , M Hajiazim , S Akhondzadeh (2010) A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia. J Clin Psychopharmacol 30:678–682.
JG Hensler (2003) Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 72:1665–1682.
JP Higgins , SG Thompson , JJ Deeks , DG Altman (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560.
M Horiguchi , HY Meltzer (2012) The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats. Psychopharmacology 221:205–215.
M Horiguchi , KE Hannaway , AE Adelekun , K Jayathilake , HY Meltzer (2012) Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist. Neuropsychopharmacology 37:2175–2183.
HC Jackson , DJ Nutt (1992) Effects of benzodiazepine receptor inverse agonists on locomotor activity and exploration in mice. Eur J Pharmacol 221:199–203.
B Le Francois , M Czesak , D Steubl , PR Albert (2008) Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55:977–985.
GK Matheson , DM Pfeifer , MB Weiberg , C Michel (1994) The effects of azapirones on serotonin1A neurons of the dorsal raphe. Gen Pharmacol 25:675–683.
HY Meltzer , M Huang (2008) In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res 172:177–197.
HY Meltzer , BW Massey (2011) The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 11:59–67.
HY Meltzer , T Sumiyoshi (2008) Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav Brain Res 195:98–102.
HY Meltzer , Z Li , Y Kaneda , J Ichikawa (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:1159–1172.
S Miyamoto , GE Duncan , CE Marx , JA Lieberman (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79–104.
NC Moore , E Meyendorff , V Yeragani , PA LeWitt , S Gershon (1987) Tiaspirone in schizophrenia. J Clin psychopharmacol 7:98–101.
A Newman-Tancredi , MS Kleven (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 216:451–473.
SV Onrust , K McClellan (2001) Perospirone. CNS Drugs 15:329–337; discussion 338.
JE Overall , DR Gorham (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812.
D Piskulic , JS Olver , P Maruff , TR Norman (2009) Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist. Hum Psychopharmacol 24:437–446.
T Sumiyoshi , Y Higuchi (2012) Facilitative effect of serotonin1A receptor agonists on cognition in patients with schizophrenia. Curr Med Chem 20:357–362.
T Sumiyoshi , M Matsui , S Nohara , I Yamashita , M Kurachi , C Sumiyoshi , K Jayathilake , HY Meltzer (2001) Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 158:1722–1725.
T Sumiyoshi , S Park , K Jayathilake , A Roy , A Ertugrul , HY Meltzer (2007) Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res 95:158–168.
T Sumiyoshi , CA Stockmeier , JC Overholser , GE Dilley , HY Meltzer (1996) Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708:209–214.
J Tauscher , S Kapur , NP Verhoeff , DF Hussey , ZJ Daskalakis , S Tauscher-Wisniewski , AA Wilson , S Houle , S Kasper , RB Zipursky (2002) Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Arch Gen Psychiatry 59:514–520.
DP Taylor , SL Moon (1991) Buspirone and related compounds as alternative anxiolytics. Neuropeptides 19 Suppl:15–19.
K Wedzony , M Mackowiak , K Fijal , K Golembiowska (1996a) Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists. Synapse 24:240–247.
K Wedzony , M Mackowiak , K Fijal , K Golembiowska (1996b) Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex. Eur J Pharmacol 305:73–78.
BD Winters , JM Reid (2010) A distributed cortical representation underlies crossmodal object recognition in rats. J Neurosci 30:6253–6261.